Skip to main content
. Author manuscript; available in PMC: 2008 Apr 30.
Published in final edited form as: Exp Eye Res. 2007 Feb 11;84(5):991–1000. doi: 10.1016/j.exer.2007.01.023

Table 2.

Elapsed time (days) from inoculation of various doses of HSV-1 to at least 95% destruction of uveal melanoma cultures of low (OCM1a) and high (MUM2B) invasive potential in the absence of Matrigel

HSV-1 inoculum dose (MOI) OCM1a (day of 95% destruction) MUM2B (day of 95% destruction)
10 2 4
1 3 5
0.1 3 7
0.01 5 7
0.001 5 14
0.0001 5 14
0.00001 7 14